Detalhe da pesquisa
1.
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.
Br J Haematol
; 2024 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556836
2.
2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management.
Am J Hematol
; 99(5): 938-945, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450790
3.
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica
; 108(12): 3321-3332, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37408464
4.
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Am J Hematol
; 98(6): 848-856, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880203
5.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633671
6.
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Blood
; 135(20): 1739-1749, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160294
7.
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(9): 1033-1062, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075392
8.
2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management.
Am J Hematol
; 96(11): 1532-1538, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536293
9.
Biology and Current Treatment of Myeloproliferative Neoplasms.
Cancer Treat Res
; 181: 151-165, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626360
10.
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1425-1432, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416253
11.
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(12): e322-e327, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866594
12.
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(6): 1084-1090, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035275
13.
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center.
Biol Blood Marrow Transplant
; 26(2): 292-299, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536825
14.
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Am J Hematol
; 95(10): 1193-1199, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628327
15.
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.
Biol Blood Marrow Transplant
; 25(5): e183-e185, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30708188
16.
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.
Biol Blood Marrow Transplant
; 25(2): 287-292, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30227232
17.
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(2): 265-269, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30201397
18.
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(9): 1828-1835, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753158
19.
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.
Haematologica
; 103(10): 1662-1668, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903756
20.
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue.
Biol Blood Marrow Transplant
; 23(8): 1264-1268, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434928